A virtual symposium
Registration will close at 12.00 BST on Monday, 12th April
Synopsis
With more than 49 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 9th RSC/SCI symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.
Programme Themes
This event will bring together industrial and academic experts representing many of the leading institutions in kinase drug discovery, to discuss a selection of new and emerging topics within the fields of kinase therapeutics for oncology and non-oncology therapies, and foster discussions within the wider industry through networking and industrial exhibitions.
Who should attend?
This event is aimed at all scientists interested in furthering their knowledge of kinases. It will also have wider appeal to members of the drug discovery community eager to understand how enzyme inhibitor programmes are approached and executed across the pharmaceutical industry.
Registration
Registration is open. and fees are
拢75 RSC or SCI member*
拢100 Non-member
拢35 RSC or SCI student** member
拢50 Student** non-member
* Member is paid-up member of the RSC or SCI.
** Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Exhibition
Exhibitor Sponsorship packages are available to book and further information may be found on our webiste.
Registration will close at 12.00 BST on Monday, 12th April
Synopsis
With more than 49 FDA-approved small molecules, the field of kinase inhibition continues to attract significant investment from the drug discovery and development community. The 9th RSC/SCI symposium on kinases will encompass plenary lectures on emergent topics and case studies of ongoing programmes as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.
Programme Themes
This event will bring together industrial and academic experts representing many of the leading institutions in kinase drug discovery, to discuss a selection of new and emerging topics within the fields of kinase therapeutics for oncology and non-oncology therapies, and foster discussions within the wider industry through networking and industrial exhibitions.
Who should attend?
This event is aimed at all scientists interested in furthering their knowledge of kinases. It will also have wider appeal to members of the drug discovery community eager to understand how enzyme inhibitor programmes are approached and executed across the pharmaceutical industry.
Registration
Registration is open. and fees are
拢75 RSC or SCI member*
拢100 Non-member
拢35 RSC or SCI student** member
拢50 Student** non-member
* Member is paid-up member of the RSC or SCI.
** Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Exhibition
Exhibitor Sponsorship packages are available to book and further information may be found on our webiste.
